Competition Bureau Prescribes Remedy for Pfizer-Hospira Deal
Following concerns that Pfizer Inc.’s proposed acquisition of Hospira Inc. will result in a substantial lessening of competition, Pfizer has reached an agreement with the Competition Bureau to sell the Canadian assets related to four pharmaceutical products distributed by the pharma giant in Canada. The Bureau was largely concerned with the supply of the following products in the Canadian pharmaceuticals market: methotrexate sodium tablets, injectable cytarabine, injectable epirubicin hydrochloride, and injectable voriconazole. Approval of the sale of these four products is in the sole discretion of the Commissioner of Competition, provided that the buyer(s) facilitate effective competition in Canada. Pfizer announced plans to acquire Hospira ... [more] Full article
Kingspan-Vicwest Merger Approved Through Consent Agreement
Kingspan, a global seller and manufacturer of building products, has reached a consent agreement with the Competition Bureau to sell a manufacturing facility in order to complete its acquisition of business ... [more] Full article
Competition Bureau Challenges Major Gas Retailer Merger
On April 30, 2015, the Competition Bureau filed an application to challenge a proposed merger between two major gas retailers, Parkland and Pioneer. Parkland proposed to acquire 181 gas stations and ... [more] Full article
Sun Media Assets Sold to Postmedia Following A Five-Month Review
Postmedia’s proposed acquisition of Sun Media’s English-language media assets was recently approved by the Competition Bureau. The $316-million deal was first announced in October 2014, which involved the acquisition of Sun Media’s 175 newspapers ... [more] Full article
Mergers Contributors
Masiel A. Matus
Masiel has a broad commercial litigation practice and represents both national and international clients in a variety of complex matters. Masiel has experience litigating cases involving professional negligence, commercial leasing and real property disputes, insurance, contract disputes, shareholder disputes, fraud, breach of fiduciary duty, breach of trust, employment matters and defamation claims.
David N. Vaillancourt
David's practice expertise focuses on all matters of Commercial and Civil Litigation, Competition and Administrative Law. David has acted for clients in a wide range of disputes, including shareholder and partnership disputes, securities litigation, class action defence, proceedings under the Competition Act, employment law disputes, contract disputes, breach of confidence/intellectual property disputes, fidelity bond claims, and professional negligence claims. David has appeared before all levels of court in Ontario, including the Court of Appeal for Ontario, and has also appeared before the Competition Tribunal and the Federal Court of Appeal. David has appeared as lead counsel in numerous trials, hearings, and motions. David has been successful in numerous adversarial proceedings, and also has successfully negotiated the resolution of dozens of cases.
